...Albert, we have about 35 minutes. So I want to start with a big picture question for you on the external environment, which I think is something that everyone is trying to figure out. You're the perfect curtain raiser for this conference, given your role as the Chair of the PhRMA lobbying group. You have a very unique perspective, and you have front row seats on what's going on in Washington DC with respect to policy and all these overhangs on the sector. So level set for us, to kick the conversation off, on where things stand in your most recent conversations with the Administration, particularly as it relates to this drug pricing MFN executive order. What should we be expecting to hear this week? I believe this week marks the 30-day mark from the time that the executive order was first put out. And what are the range of outcomes that the industry is expecting, both near term as well as how this plays out over the longer term? Albert Bourla ...
